These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8228341)

  • 1. Immunologic parameters 2 years after high-titer measles immunization in Peruvian children.
    León ME; Ward B; Kanashiro R; Hernández H; Berry S; Vaisberg A; Escamilla J; Campos M; Bellomo S; Azabache V
    J Infect Dis; 1993 Nov; 168(5):1097-104. PubMed ID: 8228341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Whittle H
    Am J Epidemiol; 1993 Nov; 138(9):746-55. PubMed ID: 8237989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential mortality by measles vaccine titer and sex.
    Holt EA; Moulton LH; Siberry GK; Halsey NA
    J Infect Dis; 1993 Nov; 168(5):1087-96. PubMed ID: 8228340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded programme on immunization (EPI). Safety of high titre measles vaccines.
    Wkly Epidemiol Rec; 1992 Nov; 67(48):357-61. PubMed ID: 1449986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term impact of high titer Edmonston-Zagreb measles vaccine on T lymphocyte subsets.
    Lisse IM; Aaby P; Knudsen K; Whittle H; Andersen H
    Pediatr Infect Dis J; 1994 Feb; 13(2):109-12. PubMed ID: 8190534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased long term mortality associated with rash after early measles vaccination in rural Senegal.
    Seng R; Samb B; Simondon F; Cissé B; Soumaré M; Jensen H; Bennett J; Whittle H; Aaby P
    Pediatr Infect Dis J; 1999 Jan; 18(1):48-52. PubMed ID: 9951980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assumptions and contradictions in measles and measles immunization research: is measles good for something?
    Aaby P
    Soc Sci Med; 1995 Sep; 41(5):673-86. PubMed ID: 7502100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccines in Peruvian infants.
    Berry S; Hernandez H; Kanashiro R; Campos M; Azabache V; Gomez G; Gutierrez M; Weirs B; De Quadros C; Halsey N
    Pediatr Infect Dis J; 1992 Oct; 11(10):822-7. PubMed ID: 1408479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence for short or long term morbidity after increased titer measles vaccination in Sudan.
    Libman MD; Ibrahim SA; Omer MI; Adlan IA; Bellavance F; Hoskins E; Bertley F; Ward B
    Pediatr Infect Dis J; 2002 Feb; 21(2):112-9. PubMed ID: 11840077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to measles vaccine in Peruvian children.
    Bautista-López NL; Vaisberg A; Kanashiro R; Hernández H; Ward BJ
    Bull World Health Organ; 2001; 79(11):1038-46. PubMed ID: 11731811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from measles vaccination in developing countries.
    Hall AJ; Cutts FT
    BMJ; 1993 Nov; 307(6915):1294-5. PubMed ID: 8257878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte subpopulations and antibody levels in immunized malnourished children.
    Salimonu LS; Johnson AO; Williams AI; Adeleye GI; Osunkoya BO
    Br J Nutr; 1982 Jul; 48(1):7-14. PubMed ID: 6809039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.
    Rosen JB; Breman JG; Manclark CR; Meade BD; Collins WE; Lobel HO; Saliou P; Roberts JM; Campaoré P; Miller MA
    Malar J; 2005 Nov; 4():53. PubMed ID: 16271153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered reactivity to measles virus: local reactions following attenuated measles virus immunization in children who previously received a combination of inactivated and attenuated vaccines.
    Fulginiti VA; Arthur JH; Pearlman DS; Kempe CH
    Am J Dis Child; 1968 Jun; 115(6):671-6. PubMed ID: 4968323
    [No Abstract]   [Full Text] [Related]  

  • 18. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
    Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.